TORVANTA
Other · S&P 500 · data as of 2026-10-05

RDNT stock analysis: RDNT

RDNT (RDNT) is an S&P 500 company in Other. It grades weakest on value and profitability.

The model's view of RDNT · subscribers

Where RDNT ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with RDNT · updated 2026-10-05 · from prices and SEC filings

RDNT price performance

RDNT against the S&P 500, one year
-20%+0%+20%S&P 500 +18%RDNT -6%2025-09-292026-10-05
Year to date-1.1%S&P 500 +14.5% · behind by 15.6 pts
1 year-9.1%S&P 500 +17.0% · behind by 26.1 pts
3 years+145.9%S&P 500 +89.3% · ahead by 56.6 pts
5 years+145.9%S&P 500 +91.3% · ahead by 54.6 pts

Total returns with dividends reinvested.

RDNT factor grades

Each grade compares RDNT with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

C-ValueFCF yield 5.6% (industry 6.0%)
BGrowthRevenue growth +19% (industry +8%)
D+ProfitabilityOperating margin 3.1% (industry 9.6%)ROIC 2.7% (industry 10.1%)
C+Momentum12-month change -9%From 52-wk high -16%

RDNT in plain numbers

RDNT key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$5.6B
Revenue growth (y/y)+19%
Free-cash-flow yield5.6%
Dividend yieldn/a
Next earnings (expected)2026-11-09
Valuation measures
Market value$5.6B
Enterprise value$6.2B
Price / sales2.4x
Price / book5.1x
EV / revenue2.7x
EV / EBITDA25.5x
Financial highlights
Revenue, last 12 months$2.3B
Net income, last 12 months-$21.1M
EPS, last 12 months (GAAP)$-0.27
Operating margin3.1%
Net margin-0.9%
Return on equity-2.1%
Return on invested capital2.7%
Cash$726.3M
Total debt$1.3B
Debt / equity1.22x
Interest cover1.0x
Current ratio1.48x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

RDNT earnings trends

Revenue vs earnings
-$37.9M$127.2M$292.4M$457.6M$622.7MSep 2024 Revenue: $461.1MDec 2024 Revenue: $477.1MMar 2025 Revenue: $471.4MJun 2025 Revenue: $498.2MSep 2025 Revenue: $522.9MDec 2025 Revenue: $547.7MMar 2026 Revenue: $575.6MJun 2026 Revenue: $622.7MSep 2024 Net income: $3.2MDec 2024 Net income: $5.3MMar 2025 Net income: -$37.9MJun 2025 Net income: $14.5MSep 2025 Net income: $5.4MDec 2025 Net income: -$597KMar 2026 Net income: -$33.5MJun 2026 Net income: $7.5MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: 0.7%Net margin: 1.1%Net margin: -8.0%Net margin: 2.9%Net margin: 1.0%Net margin: -0.1%Net margin: -5.8%Net margin: 1.2%-8%-3%3%■ Revenue ■ Net income ━ Net margin
Earnings per share$-0.5$-0.3$-0.2$0.0$0.2Sep 2024 EPS (GAAP, diluted): $0.0Dec 2024 EPS (GAAP, diluted): $0.1Mar 2025 EPS (GAAP, diluted): $-0.5Jun 2025 EPS (GAAP, diluted): $0.2Sep 2025 EPS (GAAP, diluted): $0.1Dec 2025 EPS (GAAP, diluted): $-0.0Mar 2026 EPS (GAAP, diluted): $-0.4Jun 2026 EPS (GAAP, diluted): $0.1Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted) Change from a year earlier: Sep 2025 +75% · Dec 2025 -112% · Jun 2026 -47%

From the company's 10-Q and 10-K filings with the SEC.

RDNT financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$1.3B$1.4B$1.6B$1.8B$2.0B
Net income$24.7M$10.7M$3.0M$2.8M-$18.7M
EPS (GAAP)$0.45$0.17$-0.02$0.04$-0.26

RDNT earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-10$0.10-47%+25%+5.8%
2026-05-11$-0.43n/a+22%-3.8%
2026-03-02$-0.01-112%+15%+4.8%
2025-11-10$0.07+75%+13%-1.6%
2025-08-11$0.19n/a+8%+18.3%
2025-05-12$-0.51n/a+9%+4.6%

About RDNT

HeadquartersLos Angeles, CA
Industry (SEC code)Services-Medical Laboratories
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq
FormerlyRadNet, Inc., PRIMEDEX HEALTH SYSTEMS INC

From the company's SEC registration record.

Companies similar to RDNT

CompanyMarket valueP/ERevenue growthOperating margin12-month change
RDNT RDNT$5.6Bn/a+19%3.1%-9%
EPRT EPRT$5.5B19.9x+22%62.8%-10%compare
MTG MTG$5.6B8.5x-2%n/a+1%compare
ACI ACI$5.6B67.7x+3%0.7%-31%compare
VFC VFC$5.6B22.7x-0%6.0%-4%
CACC CACC$5.5B11.7x+3%n/a+9%
VIRT VIRT$5.5B10.4x+21%n/a+91%

All Other stock ratings

Frequently asked questions

Is RDNT stock a buy?

Torvanta does not tell individuals what to buy. Its grades for RDNT are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

When does RDNT report earnings next?

Based on its filing history, Torvanta expects RDNT to report around 2026-11-09.

How has RDNT performed against the S&P 500?

Over the past year RDNT returned -9.1%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer